Probiotic Health Claim

Chr Hansen shares jump 9% on strong H1 profits

Chr Hansen shares jump 9% on strong H1 profits

By Shane Starling

First half EBIT profits for 2011-12 surged 19% to €83m at Chr Hansen as it shrugged off the effects of severe fluctuations in the price of red colorant carmine, and ongoing probiotic health claim uncertainty in Europe – its biggest yet most stagnant market.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All